A hypomorphic variant of choroideremia is associated with a novel intronic mutation that leads to exon skipping

William J. Waldock,Laura J. Taylor,Sian Sperring,Federica Staurenghi,Cristina Martinez-Fernandez de la Camara,Jennifer Whitfield,Penny Clouston,Imran H. Yusuf,Robert E. MacLaren
DOI: https://doi.org/10.1080/13816810.2023.2270554
2024-01-27
Ophthalmic Genetics
Abstract:Introduction Molecular confirmation of pathogenic sequence variants in the CHM gene is required prior to enrolment in retinal gene therapy clinical trials for choroideremia. Individuals with mild choroideremia have been reported. The molecular basis of genotype–phenotype associations is of clinical relevance since it may impact on selection for retinal gene therapy.
ophthalmology,genetics & heredity
What problem does this paper attempt to address?